期刊
CLINICAL OBSTETRICS AND GYNECOLOGY
卷 61, 期 3, 页码 508-516出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GRF.0000000000000380
关键词
genitourinary syndrome of menopause; vulvovaginal atrophy; dyspareunia; sexual dysfunction; vaginal estrogen therapy; vaginal lubricants and moisturizers
Genitourinary syndrome of menopause (GSM) describes a collection of exam findings and bothersome symptoms associated with estrogen deficiency involving changes to the labia, introitus, clitoris, vagina, urethra, and bladder. Vulvovaginal atrophy is a component of GSM. GSM is a highly prevalent medical condition with adverse effects on the health and quality of life of midlife women. There are many effective treatment options, including nonhormonal lubricants and moisturizers, physical therapy, low-dose vaginal estrogen therapy, vaginal dehydroepiandrosterone, and oral ospemifene. Despite the availability of safe and effective therapies, GSM often remains unrecognized and untreated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据